phrykt

PROCEPT BioRobotics Corp (PRCT): who owns it and who trades it

As of Nov 16, 2026, PRCT insiders reported 14 open-market sales worth $709K and 8 purchases worth $11M in the last 12 months, with 20% of the sale value made under pre-set 10b5-1 plans. The largest seller was Alaleh Nouri (Vice president), with $409K. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling PROCEPT BioRobotics

From the latest filings

Overall: more buying than selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns PRCT

255 funds and institutions reported PRCT shares worth $1.3B at the end of Q2 2026, about 100% of the company. The largest holder is BlackRock, Inc. with 8.6%.

Funds and institutions (13F) 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.8.6%
T. Rowe Price Investment Management, Inc.5.7%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.5.0%
Vanguard Portfolio Management LLC4.4%
Vanguard Capital Management LLC4.3%
Chicago Capital, LLC3.6%
State Street Corp2.8%
California State Teachers Retirement System2.7%
Geode Capital Management, LLC2.6%
FMR LLC (Fidelity)2.5%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.4.87M8.56%$110M+12%
T. Rowe Price Investment Management, Inc.3.27M5.74%$73.7M-0%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.2.82M4.96%$63.8M-9%
Vanguard Portfolio Management LLC2.53M4.44%$57.1M+4%
Vanguard Capital Management LLC2.46M4.32%$55.6M+3%
Chicago Capital, LLC2.07M3.64%$46.8M-4%
State Street Corp1.62M2.84%$36.5M+6%
California State Teachers Retirement System1.55M2.72%$68.5M+2104%
Geode Capital Management, LLC1.48M2.61%$33.5M+9%
FMR LLC (Fidelity)1.44M2.54%$32.6M-1%
T. Rowe Price Associates1.33M2.34%$30.1M+120%
Wellington Management Group LLP1.27M2.24%$28.8M+48%
Federated Hermes, Inc.1.25M2.20%$28.3M+619%
Jupiter Topco LLC1.10M1.94%$24.9M–
Frontier Capital Management Co LLC1.09M1.92%$24.6M+79%
Soleus Capital Management, L.P.1.00M1.76%$22.6M+527%
Champlain Investment Partners, LLC981,3811.72%$22.2M-14%
Baillie Gifford & Co911,7511.60%$20.6M-6%
Fiera Capital Corp774,5691.36%$17.5M-20%
LMR Partners LLP721,6081.27%$16.3M–

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, PRCT insiders reported $11M of open-market purchases and $709K of sales. 20% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$11M
8 trades, 2 people
Sales, 12 months
$709K
14 trades, 4 people
Sales under a 10b5-1 plan
20%
Share of sale value
Latest trade
Nov 6, 2026
Filed Nov 6, 2026

Purchases and sales by month

$10.5M$10.5MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 6, 2026Pooja SharmaChief Strat/Marketing OfSale4,710$19.71$92.9KForm 4
Sep 9, 2026Alaleh NouriVice presidentSale297$20.95$6.2KForm 4
Sep 9, 2026Barry L TemplinVice presidentSale373$20.95$7.8KForm 4
Aug 7, 2026Larry L WoodCEOPurchase23,900$20.85$498KForm 4
Jun 8, 2026Alaleh NouriVice presidentSale285$28.48$8.1KForm 4
Jun 8, 2026Kevin WatersCFOSale357$28.48$10.2KForm 4
Jun 8, 2026Barry L TemplinVice presidentSale358$28.48$10.2KForm 4
Mar 19, 2026Alaleh NouriVice presidentSale plan3,031$25.82$78.3KForm 4
Mar 19, 2026Alaleh NouriVice presidentSale plan2,332$26.15$61KForm 4
Mar 17, 2026Alaleh NouriVice presidentSale304$28.15$8.6KForm 4
Mar 17, 2026Kevin WatersCFOSale706$28.15$19.9KForm 4
Mar 10, 2026Alaleh NouriVice presidentSale145$26.74$3.9KForm 4
Mar 10, 2026Alaleh NouriVice presidentSale3,098$25.60$79.3KForm 4
Mar 9, 2026Antal Rohit DesaiDirectorPurchase43,581$24.08$1MForm 4
Mar 9, 2026Antal Rohit DesaiDirectorPurchase1,300$25.42$33KForm 4
Mar 9, 2026Antal Rohit DesaiDirectorPurchase53,818$24.91$1.3MForm 4
Mar 6, 2026Antal Rohit DesaiDirectorPurchase53,763$24.10$1.3MForm 4
Mar 6, 2026Antal Rohit DesaiDirectorPurchase106,554$23.33$2.5MForm 4
Mar 6, 2026Alaleh NouriVice presidentSale6,892$23.70$163KForm 4
Mar 6, 2026Kevin WatersCFOSale6,721$23.70$159KForm 4
Mar 5, 2026Antal Rohit DesaiDirectorPurchase142,498$25.44$3.6MForm 4
Mar 5, 2026Antal Rohit DesaiDirectorPurchase24,748$26.41$654KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Antal Rohit DesaiDirector$10.5M–Mar 9, 2026
Larry L WoodPresident, CEO, Director$498K–Aug 7, 2026
Alaleh NouriEVP, CLO, CORP. SEC.–$409KSep 9, 2026
Kevin WatersEVP, CFO–$189KJun 8, 2026
Pooja SharmaChief Strat/Marketing Officer–$92.9KNov 6, 2026
Barry L TemplinEVP, Chief Technology Officer–$18KSep 9, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

PRCT short interest

High short interest. 13.7% of PRCT shares are sold short: about 1 share in 7. Over the last 12 reports the number of shares short went up 17%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 7.86M PRCT shares were sold short, 13.7% of the shares outstanding, up 4.8% from the report before. At the average daily volume of 871,513 shares, buying them all back would take about 9.0 trading days (days to cover).

Shares short, % of all shares

13.7%May 15Oct 3013.9%

Days to cover

9.0May 15Oct 309.9

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20267.86M13.66%+5%871,5139.0
Oct 15, 20267.50M13.10%+1%1.35M5.6
Sep 30, 20267.43M12.97%-0%1.40M5.3
Sep 15, 20267.44M12.99%+3%1.34M5.6
Aug 31, 20267.25M12.66%-6%846,3058.6
Aug 14, 20267.71M13.45%+9%2.22M3.5
Jul 31, 20267.09M12.38%-9%1.38M5.1
Jul 15, 20267.75M13.62%+1%1.59M4.9
Jun 30, 20267.65M13.45%+1%1.97M3.9
Jun 15, 20267.61M13.37%+12%1.40M5.4
May 29, 20266.78M11.92%+1%1.26M5.4
May 15, 20266.72M11.81%+12%1.67M4.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

PROCEPT BioRobotics company events

PROCEPT BioRobotics filed 9 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026ResultsReleased financial results. Filing
  2. Oct 2, 2026LeadershipThe board of directors of PROCEPT BioRobotics Corporation approved (i) an increase in the size of the Board from nine members to ten members, (ii) appointed Dr. Michael Mack as a new member of the Board to fill the resulting vacancy, effective immediately. Filing
  3. Sep 24, 2026AgreementPROCEPT BioRobotics Corporation entered into a Third Amendment to Loan and Security Agreement with Canadian Imperial Bank of Commerce, which amends the Loan and Security Agreement, dated as of October 6, 2022, by and between the Company and CIBC, as previously amended by the First Amendment to Loan… Filing
  4. Aug 4, 2026ResultsReleased financial results. Filing
  5. Jun 10, 2026VoteReported shareholder vote results. Filing
  6. Apr 29, 2026ResultsReleased financial results. Filing
  7. Mar 6, 2026LeadershipThe board of directors of PROCEPT BioRobotics Corporation approved (i) an increase in the size of the Board from eight members to nine members, (ii) appointed Mr. Daniel Puckett as a new member of the Board to fill the resulting vacancy, and (iii) appointed Mr. Puckett as a member of the Audit… Filing
  8. Feb 26, 2026AnnouncementShared information with investors. Filing
  9. Feb 25, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

PROCEPT BioRobotics financials

Famous investors that hold PRCT

2 of the 50 well-known investors we track reported holding PRCT in their latest 13F filing. The largest position is Israel Englander's, worth $22.2M.

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 20261.22M$22.2M0.0%+95%
Ken Griffin · Citadel AdvisorsQ3 2026278,073$5.1M0.0%+2105%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named PRCT in the last 120 days.

FiledHolderFormStake
Oct 30, 2026Vanguard Capital Management13G/A5.0%
Oct 30, 2026Vanguard Capital Management13G/A5.0%

Questions about PROCEPT BioRobotics Corp (PRCT) stock

Who owns the most PRCT stock?

The largest reported owner of PROCEPT BioRobotics Corp (PRCT) is BlackRock, Inc., with 8.6% of the company. In total, 255 funds and institutions reported holding PRCT at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are PRCT insiders buying or selling?

In the last 12 months, PRCT insiders reported 8 open-market purchases worth $11M and 14 sales worth $709K. The latest trade was on Nov 6, 2026. See every trade.

What is the short interest in PRCT?

As of Oct 30, 2026, 7.86M PRCT shares were sold short, 13.7% of the shares outstanding, up 4.8% from the report before. At the average daily volume of 871,513 shares, buying them all back would take about 9.0 trading days (days to cover). See the history.

Which famous investors hold PRCT?

2 of the 50 well-known investors we track reported PRCT in their latest 13F filing, including Israel Englander, Ken Griffin. The largest position is worth $22.2M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.